Endovascular treatment of external iliac artery stenoses for claudication with systematic stenting
Blandine Maurel1, Julien Lancelevee, David Jacobi
1Service de Chirurgie Vasculaire, CHRU de Tours, Tours, France. maurel.blandine@yahoo.fr
Insights
Systematic stenting of external iliac artery lesions effectively treats claudication, showing high patency rates and low complications. This endovascular approach offers satisfying outcomes for patients with this condition.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapeutics
Background:
- Limited data exists on endovascular treatment outcomes specifically for external iliac artery (EIA) lesions causing claudication.
- Existing literature often combines claudication and acute ischemia, and does not differentiate between EIA and common iliac artery lesions.
- The role of systematic stenting for EIA atheromatous lesions remains a subject of debate.
Purpose of the Study:
- To evaluate the outcomes of systematic stenting for atheromatous lesions of the external iliac artery.
- To assess results in a consecutive and homogenous population of patients experiencing claudication.
- To analyze patency rates, complication rates, and clinical outcomes following endovascular treatment.
Main Methods:
- A cohort of 81 consecutive patients (90 EIA lesions) with claudication underwent systematic stenting between June 2000 and December 2006.
- Lesions were classified using the Trans-Atlantic Intersociety Consensus (TASC) criteria; endovascular treatment was systematically chosen for TASC A and B, and high-risk TASC C and D.
- Clinical examinations and duplex ultrasound follow-ups were performed, with a mean follow-up of 23 months.
Main Results:
- A low complication rate of 2.2% was observed, with no deaths.
- Primary patency rates were 97% at 1 year, 90% at 2 years, and 84% at 3 years; secondary patency rates were 98% at 1 year, 93% at 2 years, and 93% at 3 years.
- Most patients became asymptomatic or reported moderate claudication post-treatment; TASC C or D classification trended towards earlier restenosis (p=0.06).
Conclusions:
- Systematic stenting of external iliac artery atheromatous lesions in patients with claudication yields satisfying clinical results.
- The study demonstrates high patency rates and a low complication profile in a larger patient cohort than previously reported.
- Endovascular treatment with systematic stenting is a viable option for managing external iliac artery lesions causing claudication.
Abstract:
The results of the endovascular treatment of external iliac artery lesions in patients with claudication are not well known. In the literature, very often, the studied populations are not homogenous (people with claudication and with acute ischemia) and the external iliac artery is not differentiated from the primary iliac artery. Moreover, systematic stenting is still debated. Our goal was to study the results of systematic stenting for atheromatous lesions of the external iliac artery in a consecutive and homogenous population of patients with claudication. From June 2000 to December 2006, 90 external iliac arteries were treated with systematic stenting for atheromatous lesions in 81 consecutive patients with claudication (74 men and 7 women, aged 62+/-12 years). Lesions were classified according to the Trans-Atlantic Intersociety Consensus (TASC). Endovascular treatment was systematically chosen for TASC A (n=40) and B (n=30) patients and patients at high surgical risk for TASC C (n=18) and D (n=2). One hundred and seven stents were placed; they were 37+/-21 mm long with a 7+/-0.6mm diameter. Clinical examination and duplex follow-up were carried out at a minimum of 3 months and at the end of the follow-up. There was a 2.2% complication rate, without any deaths (retroperitoneal hematoma). Mean follow-up was 23 months (with a 13-month median). Primary patency rate was 97% (standard error [SE] 2%) at 1 year, 90% (SE 4.6%) at 2 years, and 84% (SE 6.6%) at 3 years. Secondary patency rate was 98% (SE 1.5%) at 1 year, 93% (SE 3.9%) at 2 years, and 93% (SE 4.5%) at 3 years. Ten restenoses were detected and treated by endovascular techniques (n=6), bypass (n=2), or medication (n=2). At the end of the follow-up, the patients were asymptomatic (n=62) or presented with a moderate (n=17) or severe (n=8) claudication. A patient with hemodialysis was amputated at the metatarsal level. No significant predictive restenosis factor was discovered. However, the C or D TASC classification seemed to favor an earlier restenosis (p=0.06). In conclusion, our study demonstrates that, in a larger population than in the literature, systematic stenting on the external iliac artery gives satisfying results in patients with claudication.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Venous Thrombosis III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Atherosclerosis III: Management
